Cargando…

Dispensary Cannabidiol (CBD): Nothing to Worry About!

Introduction: Despite US FDA approval of cannabidiol (CBD) liquid (Epidiolex®), patients with epilepsy still supplement prescription treatments with dispensary CBD. This study aimed to evaluate therapeutic effectiveness of dispensary CBD. Methods: We retrospectively collected dosage information, CBD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elliott, Taylor, Gienapp, Andrew J., Wheless, James W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123877/ https://www.ncbi.nlm.nih.gov/pubmed/37101430 http://dx.doi.org/10.1177/2329048X231169395

Ejemplares similares

The ‘Disappearing’ Liver on CEUS: Nothing to Worry About
por: Müller, Thomas, et al.
Publicado: (2019)

Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022)

The use of cannabidiol (CBD) as an analgesic component
por: Petersen, Kristian Kjær-Staal, et al.
Publicado: (2023)

Towards Better Delivery of Cannabidiol (CBD)
por: Millar, Sophie Anne, et al.
Publicado: (2020)

Cannabidiol (CBD) and Insomnia : Literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022)

Covid and cholesterol (C&C): Something to worry about or much ado about nothing?
por: Garg, Heena, et al.
Publicado: (2021)

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study
por: Sharma, Pravesh, et al.
Publicado: (2022)

Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD)
por: Nasrin, Shamema, et al.
Publicado: (2023)

The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
por: Peyravian, Nadia, et al.
Publicado: (2022)

Trends in Internet Searches for Cannabidiol (CBD) in the United States
por: Leas, Eric C., et al.
Publicado: (2019)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022)

Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
por: Gelmi, Tim J., et al.
Publicado: (2021)

Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies
por: Leas, Eric C., et al.
Publicado: (2020)

Looped suction catheter in an i-gel™; something to worry about or much ado about nothing?
por: Naik, B Naveen, et al.
Publicado: (2019)

Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
por: Failing, Christopher J, et al.
Publicado: (2021)

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
por: Seltzer, Emily S., et al.
Publicado: (2020)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
por: Baswan, Sudhir M, et al.
Publicado: (2020)

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
por: Heider, Camren G., et al.
Publicado: (2022)

Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
por: Leas, Eric C., et al.
Publicado: (2021)

Commentary regarding 'Looped suction catheter in an i-gel™; something to worry about or much ado about nothing?'
por: Kaur, Manbir, et al.
Publicado: (2020)

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017)

Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome
por: Salles, Évila Lopes, et al.
Publicado: (2020)

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)

Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis
por: Mathur, Karan, et al.
Publicado: (2019)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
por: Lachenmeier, Dirk W., et al.
Publicado: (2023)

The Use of Cannabidiol in Metabolic Syndrome—An Opportunity to Improve the Patient’s Health or Much Ado about Nothing?
por: Wiciński, Michał, et al.
Publicado: (2023)

Cannabidiol (CBD) Supports the Honeybee Worker Organism by Activating the Antioxidant System
por: Skowronek, Patrycja, et al.
Publicado: (2023)

Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
por: Lowin, Torsten, et al.
Publicado: (2020)

Nothing to smile about
por: Luca, Maria, et al.
Publicado: (2014)

Staff awareness of the use of cannabidiol (CBD): a trust-wide survey study in the UK
por: Ukaegbu, Obioha, et al.
Publicado: (2021)

Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim
por: Johnson, Erin, et al.
Publicado: (2022)

You have nothing to lose: Worry-free flipping for PSE
por: Lewin, Daniel R.
Publicado: (2022)

Hair Regrowth with Cannabidiol (CBD)-rich Hemp Extract – A Case Series
por: Smith, Gregory L., et al.
Publicado: (2021)

Cannabidiol in sports: insights on how CBD could improve performance and recovery
por: Rojas-Valverde, Daniel, et al.
Publicado: (2023)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

Cannabidiol (CBD) oil toxicity mimicking extraglandular complications of Sjögren’s syndrome
por: Madera-Acosta, Adria, et al.
Publicado: (2021)

Photochemistry of Cannabidiol (CBD) Revised. A Combined Preparative and Spectrometric Investigation
por: Seccamani, Paolo, et al.
Publicado: (2021)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
por: Crippa, José A., et al.
Publicado: (2018)

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
por: Kosgodage, Uchini S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ffs5jeis76kasluhk63f1t3aom